欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Nityr Human nitisinone nitisinone EMEA/H/C/004582 Cycle Pharmaceuticals (Europe) Ltd 2018/07/26 Authorised
Halimatoz Human adalimumab adalimumab EMEA/H/C/004866 Sandoz GmbH 2018/07/26 Withdrawn
Carmustine medac (previously Carmustine Obvius) Human carmustine carmustine EMEA/H/C/004326 medac Gesellschaft für klinische Spezialpräparate mbH 2018/07/18 Authorised
Tegsedi Human inotersen inotersen sodium EMEA/H/C/004782 Akcea Therapeutics Ireland Limited 2018/07/06 Authorised
Verkazia Human ciclosporin ciclosporin EMEA/H/C/004411 Santen Oy 2018/07/06 Authorised
Graspa Human asparaginase asparaginase EMEA/H/C/004736 ERYTECH Pharma S.A. 2018/06/27 Application withdrawn
Dzuveo Human sufentanil sufentanil citrate EMEA/H/C/004335 Laboratoire Aguettant 2018/06/25 Authorised
Biktarvy Human bictegravir;emtricitabine;tenofovir alafenamide bictegravir;emtricitabine;tenofovir alafenamide;fumarate EMEA/H/C/004449 Gilead Sciences Ireland UC 2018/06/21 Authorised
Amglidia Human glibenclamide glibenclamide EMEA/H/C/004379 Ammtek 2018/05/24 Authorised
Rubraca Human rucaparib Rucaparib camsylate EMEA/H/C/004272 pharmaand GmbH 2018/05/23 Authorised
Pemetrexed Krka Human pemetrexed pemetrexed disodium EMEA/H/C/003958 KRKA d.d. 2018/05/22 Withdrawn
Zessly Human infliximab infliximab EMEA/H/C/004647 Sandoz GmbH 2018/05/18 Authorised
Juluca Human dolutegravir;rilpivirine dolutegravir sodium;rilpivirine hydrochloride EMEA/H/C/004427 ViiV Healthcare B.V. 2018/05/16 Authorised
Kanjinti Human trastuzumab trastuzumab EMEA/H/C/004361 Amgen Europe B.V. 2018/05/16 Authorised
Prasugrel Viatris (previously Prasugrel Mylan) Human prasugrel prasugrel besilate EMEA/H/C/004644 Mylan Pharmaceuticals Limited 2018/05/15 Authorised
Trydonis Human beclometasone;formoterol;glycopyrronium bromide beclometasone dipropionate;formoterol fumarate dihydrate;glycopyrronium EMEA/H/C/004702 Chiesi Farmaceutici S.p.A. 2018/04/26 Authorised
Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) Human beclometasone;formoterol formoterol fumarate dihydrate;glycopyrronium;beclometasone dipropionate EMEA/H/C/004836 Chiesi Farmaceutici S.p.A. 2018/04/23 Withdrawn
Mylotarg Human gemtuzumab ozogamicin gemtuzumab ozogamicin EMEA/H/C/004204 Pfizer Europe MA EEIG 2018/04/19 Authorised
Alpivab Human peramivir peramivir EMEA/H/C/004299 Biocryst 2018/04/13 Withdrawn
Steglujan Human ertugliflozin;sitagliptin ertugliflozin l-pyroglutamic acid;sitagliptin phosphate monohydrate EMEA/H/C/004313 Merck Sharp & Dohme B.V. 2018/03/23 Authorised

数据库说明:

©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase